search buttonmobile navigation expand button

Need Assistance?

Back to Search Results


RIN-PH-201 (INCREASE): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease
The purpose of this study is to investigate the safety of inhaled Treprostinil and how well it works in subjects with Pulmonary Hypertension (PH) associated with Interstitial Lung Disease (ILD) or Combined Pulmonary Fibrosis and Emphysema (CPFE).  This study will look at your ability to exercise after taking the study drug.
Trial Information
Principal Investigator: Dr. Majid Mughal, MD

Contact: Study Coordinator
Phone (Main): 517-347-1968

IRB Number: 2017-00044 02630316

More Information: